These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 31896079)
1. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA. Azad TD; Jin MC; Bernhardt LJ; Bettegowda C Neurosurg Focus; 2020 Jan; 48(1):E9. PubMed ID: 31896079 [TBL] [Abstract][Full Text] [Related]
2. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas. Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443 [TBL] [Abstract][Full Text] [Related]
3. Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR. Li D; Bonner ER; Wierzbicki K; Panditharatna E; Huang T; Lulla R; Mueller S; Koschmann C; Nazarian J; Saratsis AM Sci Rep; 2021 Mar; 11(1):5098. PubMed ID: 33658570 [TBL] [Abstract][Full Text] [Related]
4. Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy. Panditharatna E; Kilburn LB; Aboian MS; Kambhampati M; Gordish-Dressman H; Magge SN; Gupta N; Myseros JS; Hwang EI; Kline C; Crawford JR; Warren KE; Cha S; Liang WS; Berens ME; Packer RJ; Resnick AC; Prados M; Mueller S; Nazarian J Clin Cancer Res; 2018 Dec; 24(23):5850-5859. PubMed ID: 30322880 [TBL] [Abstract][Full Text] [Related]
5. Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid. Fujioka Y; Hata N; Akagi Y; Kuga D; Hatae R; Sangatsuda Y; Michiwaki Y; Amemiya T; Takigawa K; Funakoshi Y; Sako A; Iwaki T; Iihara K; Mizoguchi M J Neurooncol; 2021 Mar; 152(1):47-54. PubMed ID: 33417137 [TBL] [Abstract][Full Text] [Related]
6. Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma. Bruzek AK; Ravi K; Muruganand A; Wadden J; Babila CM; Cantor E; Tunkle L; Wierzbicki K; Stallard S; Dickson RP; Wolfe I; Mody R; Schwartz J; Franson A; Robertson PL; Muraszko KM; Maher CO; Garton HJL; Qin T; Koschmann C Clin Cancer Res; 2020 Dec; 26(23):6266-6276. PubMed ID: 33087334 [TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. Pan C; Diplas BH; Chen X; Wu Y; Xiao X; Jiang L; Geng Y; Xu C; Sun Y; Zhang P; Wu W; Wang Y; Wu Z; Zhang J; Jiao Y; Yan H; Zhang L Acta Neuropathol; 2019 Feb; 137(2):297-306. PubMed ID: 30460397 [TBL] [Abstract][Full Text] [Related]
8. Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Huang TY; Piunti A; Lulla RR; Qi J; Horbinski CM; Tomita T; James CD; Shilatifard A; Saratsis AM Acta Neuropathol Commun; 2017 Apr; 5(1):28. PubMed ID: 28416018 [TBL] [Abstract][Full Text] [Related]
9. Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors. Ronsley R; Karvonen KA; Cole B; Paulson V; Stevens J; Crotty EE; Hauptman J; Lee A; Stasi SM; Lockwood CM; Leary SES J Neurooncol; 2024 Jun; 168(2):215-224. PubMed ID: 38755519 [TBL] [Abstract][Full Text] [Related]
10. Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma. Cantor E; Wierzbicki K; Tarapore RS; Ravi K; Thomas C; Cartaxo R; Nand Yadav V; Ravindran R; Bruzek AK; Wadden J; John V; May Babila C; Cummings JR; Rahman Kawakibi A; Ji S; Ramos J; Paul A; Walling D; Leonard M; Robertson P; Franson A; Mody R; Garton HJL; Venneti S; Odia Y; Kline C; Vitanza NA; Khatua S; Mueller S; Allen JE; Gardner SL; Koschmann C Neuro Oncol; 2022 Aug; 24(8):1366-1374. PubMed ID: 35137228 [TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy in H3K27M diffuse midline glioma. Patel J; Aittaleb R; Doherty R; Gera A; Lau B; Messinger D; Wadden J; Franson A; Saratsis A; Koschmann C Neuro Oncol; 2024 May; 26(Supplement_2):S101-S109. PubMed ID: 38096156 [TBL] [Abstract][Full Text] [Related]
12. Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid. Martínez-Ricarte F; Mayor R; Martínez-Sáez E; Rubio-Pérez C; Pineda E; Cordero E; Cicuéndez M; Poca MA; López-Bigas N; Ramon Y Cajal S; Vieito M; Carles J; Tabernero J; Vivancos A; Gallego S; Graus F; Sahuquillo J; Seoane J Clin Cancer Res; 2018 Jun; 24(12):2812-2819. PubMed ID: 29615461 [No Abstract] [Full Text] [Related]
13. Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic? Simonelli M; Dipasquale A; Orzan F; Lorenzi E; Persico P; Navarria P; Pessina F; Nibali MC; Bello L; Santoro A; Boccaccio C Crit Rev Oncol Hematol; 2020 Feb; 146():102879. PubMed ID: 32005411 [TBL] [Abstract][Full Text] [Related]
14. Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients. Izquierdo E; Proszek P; Pericoli G; Temelso S; Clarke M; Carvalho DM; Mackay A; Marshall LV; Carceller F; Hargrave D; Lannering B; Pavelka Z; Bailey S; Entz-Werle N; Grill J; Vassal G; Rodriguez D; Morgan PS; Jaspan T; Mastronuzzi A; Vinci M; Hubank M; Jones C Neurooncol Adv; 2021; 3(1):vdab013. PubMed ID: 34169282 [TBL] [Abstract][Full Text] [Related]
15. Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine. Pagès M; Rotem D; Gydush G; Reed S; Rhoades J; Ha G; Lo C; Fleharty M; Duran M; Jones R; Becker S; Haller M; Sinai CE; Goumnerova L; Golub TR; Love JC; Ligon KL; Wright KD; Adalsteinsson VA; Beroukhim R; Bandopadhayay P Neuro Oncol; 2022 Aug; 24(8):1352-1363. PubMed ID: 34984433 [TBL] [Abstract][Full Text] [Related]
16. Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: a review for practicing neurosurgeons. Bounajem MT; Karsy M; Jensen RL Neurosurg Focus; 2020 Jan; 48(1):E8. PubMed ID: 31896088 [TBL] [Abstract][Full Text] [Related]
17. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas. Hickmann AK; Frick M; Hadaschik D; Battke F; Bittl M; Ganslandt O; Biskup S; Döcker D BMC Cancer; 2019 Mar; 19(1):192. PubMed ID: 30823914 [TBL] [Abstract][Full Text] [Related]
18. [The Present and Future of Less-invasive Liquid Biopsy for the Diagnosis of Gliomas and Brain Tumors]. Natsumeda M; On J; Watanabe J; Tsukamoto Y; Okada M; Fujii Y; Adachi J; Nishikawa R No Shinkei Geka; 2021 May; 49(3):527-534. PubMed ID: 34092558 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid. Cornelli L; Van Paemel R; Ferro Dos Santos MR; Roelandt S; Willems L; Vandersteene J; Baert E; Mus LM; Van Roy N; De Wilde B; De Preter K Clin Epigenetics; 2024 Jul; 16(1):87. PubMed ID: 38970137 [TBL] [Abstract][Full Text] [Related]
20. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples. Ma C; Yang X; Xing W; Yu H; Si T; Guo Z Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]